The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Tizanidine-Global Market Insights and Sales Trends 2025
Synopsis
Tizanidine (trade names Zanaflex (Acorda Therapeutics), Sirdalud (Novartis), Relentus (Beximco Pharma)) is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia.
The global Tizanidine market size is expected to reach US$ 530.7 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Tizanidine in various end use industries. The expanding demands from the Kids and Adults, are propelling Tizanidine market. 2mg Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 4mg Tablet segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Tizanidine market, driven by demand from China, the second largest economy with some signs of stabilising, the Tizanidine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tizanidine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tizanidine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tizanidine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tizanidine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tizanidine covered in this report include Actavis, Teva, Sandoz, Acorda, Unichem Laboratories, APOTEX, Sun Pharmaceutical, CorePharma and Dr. Reddy's Laboratories, etc.
The global Tizanidine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Actavis
Teva
Sandoz
Acorda
Unichem Laboratories
APOTEX
Sun Pharmaceutical
CorePharma
Dr. Reddy's Laboratories
Mylan
Oxford PharmaGenesis
Niche Generics Limited
CREDIT PHARMA
YABANG
Global Tizanidine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tizanidine market, Segment by Type:
2mg Tablet
4mg Tablet
2mg Capsules
4mg Capsules
6mg Capsules
Global Tizanidine market, by Application
Kids
Adults
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tizanidine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tizanidine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Tizanidine (trade names Zanaflex (Acorda Therapeutics), Sirdalud (Novartis), Relentus (Beximco Pharma)) is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia.
The global Tizanidine market size is expected to reach US$ 530.7 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Tizanidine in various end use industries. The expanding demands from the Kids and Adults, are propelling Tizanidine market. 2mg Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 4mg Tablet segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Tizanidine market, driven by demand from China, the second largest economy with some signs of stabilising, the Tizanidine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tizanidine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tizanidine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tizanidine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tizanidine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tizanidine covered in this report include Actavis, Teva, Sandoz, Acorda, Unichem Laboratories, APOTEX, Sun Pharmaceutical, CorePharma and Dr. Reddy's Laboratories, etc.
The global Tizanidine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Actavis
Teva
Sandoz
Acorda
Unichem Laboratories
APOTEX
Sun Pharmaceutical
CorePharma
Dr. Reddy's Laboratories
Mylan
Oxford PharmaGenesis
Niche Generics Limited
CREDIT PHARMA
YABANG
Global Tizanidine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tizanidine market, Segment by Type:
2mg Tablet
4mg Tablet
2mg Capsules
4mg Capsules
6mg Capsules
Global Tizanidine market, by Application
Kids
Adults
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tizanidine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tizanidine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Tizanidine Market Overview
1.1 Tizanidine Product Overview
1.2 Tizanidine Market Segment by Type
1.2.1 2mg Tablet
1.2.2 4mg Tablet
1.2.3 2mg Capsules
1.2.4 4mg Capsules
1.2.5 6mg Capsules
1.3 Global Tizanidine Market Size by Type
1.3.1 Global Tizanidine Market Size Overview by Type (2018-2029)
1.3.2 Global Tizanidine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Tizanidine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tizanidine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Tizanidine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Tizanidine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Tizanidine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Tizanidine Sales Breakdown by Type (2018-2023)
2 Global Tizanidine Market Competition by Company
2.1 Global Top Players by Tizanidine Sales (2018-2023)
2.2 Global Top Players by Tizanidine Revenue (2018-2023)
2.3 Global Top Players by Tizanidine Price (2018-2023)
2.4 Global Top Manufacturers Tizanidine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tizanidine Market Competitive Situation and Trends
2.5.1 Tizanidine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Tizanidine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tizanidine as of 2022)
2.7 Date of Key Manufacturers Enter into Tizanidine Market
2.8 Key Manufacturers Tizanidine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tizanidine Status and Outlook by Region
3.1 Global Tizanidine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Tizanidine Historic Market Size by Region
3.2.1 Global Tizanidine Sales in Volume by Region (2018-2023)
3.2.2 Global Tizanidine Sales in Value by Region (2018-2023)
3.2.3 Global Tizanidine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Tizanidine Forecasted Market Size by Region
3.3.1 Global Tizanidine Sales in Volume by Region (2024-2029)
3.3.2 Global Tizanidine Sales in Value by Region (2024-2029)
3.3.3 Global Tizanidine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Tizanidine by Application
4.1 Tizanidine Market Segment by Application
4.1.1 Kids
4.1.2 Adults
4.2 Global Tizanidine Market Size by Application
4.2.1 Global Tizanidine Market Size Overview by Application (2018-2029)
4.2.2 Global Tizanidine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Tizanidine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tizanidine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Tizanidine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Tizanidine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Tizanidine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Tizanidine Sales Breakdown by Application (2018-2023)
5 North America Tizanidine by Country
5.1 North America Tizanidine Historic Market Size by Country
5.1.1 North America Tizanidine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Tizanidine Sales in Volume by Country (2018-2023)
5.1.3 North America Tizanidine Sales in Value by Country (2018-2023)
5.2 North America Tizanidine Forecasted Market Size by Country
5.2.1 North America Tizanidine Sales in Volume by Country (2024-2029)
5.2.2 North America Tizanidine Sales in Value by Country (2024-2029)
6 Europe Tizanidine by Country
6.1 Europe Tizanidine Historic Market Size by Country
6.1.1 Europe Tizanidine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Tizanidine Sales in Volume by Country (2018-2023)
6.1.3 Europe Tizanidine Sales in Value by Country (2018-2023)
6.2 Europe Tizanidine Forecasted Market Size by Country
6.2.1 Europe Tizanidine Sales in Volume by Country (2024-2029)
6.2.2 Europe Tizanidine Sales in Value by Country (2024-2029)
7 Asia-Pacific Tizanidine by Region
7.1 Asia-Pacific Tizanidine Historic Market Size by Region
7.1.1 Asia-Pacific Tizanidine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Tizanidine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Tizanidine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Tizanidine Forecasted Market Size by Region
7.2.1 Asia-Pacific Tizanidine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Tizanidine Sales in Value by Region (2024-2029)
8 Latin America Tizanidine by Country
8.1 Latin America Tizanidine Historic Market Size by Country
8.1.1 Latin America Tizanidine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Tizanidine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Tizanidine Sales in Value by Country (2018-2023)
8.2 Latin America Tizanidine Forecasted Market Size by Country
8.2.1 Latin America Tizanidine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Tizanidine Sales in Value by Country (2024-2029)
9 Middle East and Africa Tizanidine by Country
9.1 Middle East and Africa Tizanidine Historic Market Size by Country
9.1.1 Middle East and Africa Tizanidine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Tizanidine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Tizanidine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Tizanidine Forecasted Market Size by Country
9.2.1 Middle East and Africa Tizanidine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Tizanidine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Actavis
10.1.1 Actavis Company Information
10.1.2 Actavis Introduction and Business Overview
10.1.3 Actavis Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Actavis Tizanidine Products Offered
10.1.5 Actavis Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Tizanidine Products Offered
10.2.5 Teva Recent Development
10.3 Sandoz
10.3.1 Sandoz Company Information
10.3.2 Sandoz Introduction and Business Overview
10.3.3 Sandoz Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sandoz Tizanidine Products Offered
10.3.5 Sandoz Recent Development
10.4 Acorda
10.4.1 Acorda Company Information
10.4.2 Acorda Introduction and Business Overview
10.4.3 Acorda Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Acorda Tizanidine Products Offered
10.4.5 Acorda Recent Development
10.5 Unichem Laboratories
10.5.1 Unichem Laboratories Company Information
10.5.2 Unichem Laboratories Introduction and Business Overview
10.5.3 Unichem Laboratories Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Unichem Laboratories Tizanidine Products Offered
10.5.5 Unichem Laboratories Recent Development
10.6 APOTEX
10.6.1 APOTEX Company Information
10.6.2 APOTEX Introduction and Business Overview
10.6.3 APOTEX Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 APOTEX Tizanidine Products Offered
10.6.5 APOTEX Recent Development
10.7 Sun Pharmaceutical
10.7.1 Sun Pharmaceutical Company Information
10.7.2 Sun Pharmaceutical Introduction and Business Overview
10.7.3 Sun Pharmaceutical Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sun Pharmaceutical Tizanidine Products Offered
10.7.5 Sun Pharmaceutical Recent Development
10.8 CorePharma
10.8.1 CorePharma Company Information
10.8.2 CorePharma Introduction and Business Overview
10.8.3 CorePharma Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 CorePharma Tizanidine Products Offered
10.8.5 CorePharma Recent Development
10.9 Dr. Reddy's Laboratories
10.9.1 Dr. Reddy's Laboratories Company Information
10.9.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.9.3 Dr. Reddy's Laboratories Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Dr. Reddy's Laboratories Tizanidine Products Offered
10.9.5 Dr. Reddy's Laboratories Recent Development
10.10 Mylan
10.10.1 Mylan Company Information
10.10.2 Mylan Introduction and Business Overview
10.10.3 Mylan Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Mylan Tizanidine Products Offered
10.10.5 Mylan Recent Development
10.11 Oxford PharmaGenesis
10.11.1 Oxford PharmaGenesis Company Information
10.11.2 Oxford PharmaGenesis Introduction and Business Overview
10.11.3 Oxford PharmaGenesis Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Oxford PharmaGenesis Tizanidine Products Offered
10.11.5 Oxford PharmaGenesis Recent Development
10.12 Niche Generics Limited
10.12.1 Niche Generics Limited Company Information
10.12.2 Niche Generics Limited Introduction and Business Overview
10.12.3 Niche Generics Limited Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Niche Generics Limited Tizanidine Products Offered
10.12.5 Niche Generics Limited Recent Development
10.13 CREDIT PHARMA
10.13.1 CREDIT PHARMA Company Information
10.13.2 CREDIT PHARMA Introduction and Business Overview
10.13.3 CREDIT PHARMA Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 CREDIT PHARMA Tizanidine Products Offered
10.13.5 CREDIT PHARMA Recent Development
10.14 YABANG
10.14.1 YABANG Company Information
10.14.2 YABANG Introduction and Business Overview
10.14.3 YABANG Tizanidine Sales, Revenue and Gross Margin (2018-2023)
10.14.4 YABANG Tizanidine Products Offered
10.14.5 YABANG Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tizanidine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tizanidine Industrial Chain Analysis
11.4 Tizanidine Market Dynamics
11.4.1 Tizanidine Industry Trends
11.4.2 Tizanidine Market Drivers
11.4.3 Tizanidine Market Challenges
11.4.4 Tizanidine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tizanidine Distributors
12.3 Tizanidine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
